TESSLIFT is a global medical technology company, dedicated to the development and commercialization of the world's first invented mesh implants for tissue approximations. The company delivers improved aesthetic and clinical outcomes via a portfolio of advanced mesh scaffolding suture implants, branded as TESSLIFT®, and its biomechanically designed delivery tools. The company’s R&D model leads by its team of surgeons and biomedical engineers and defines the path to identifying and developing revolutionary ideas in the areas of soft tissues approximations technology. Having been registered under 48 countries, TESSLIFT®’s proprietary technology is being developed and manufactured at the company’s own facility in South Korea, which are compliant with all applicable regulatory standards under CE, ISO13485, and KGMP. Over decades of research contributed by world-renowned surgeons and biomedical engineers, TESSLIFT is a global partner of choice and is uniquely able to provide seamless offerings from development and manufacturing to training and education services at every stage for medical aesthetics products. Through continuous research and global expansion efforts, TESSLIFT now offers a wide range of state-of-the-art products in the field of minimally invasive aesthetics medicine.
“We Envision Beautiful Lives and Lifestyles with Innovation.”
Our Envisioning Strategy
At TESSLIFT, we constantly work towards envisioning access to high quality and safe products to support and improve the lifestyles of consumers. Our state-of-the-art innovations in products, people, and processes have been trusted by our clients, health care professionals, and daily consumers around the globe. The continual efforts to making changes in lives of consumers have inspired every aspect of TESSLIFT's work.
At a Glance:
TESSLIFT is the World’s Leading Medical Aesthetics Company with
Channels Established in
Global Partnerships with
IPs Registered Under
Global Training Workshops Held
No.1 Market Share in